Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$64.9M
-
Value change
-
+$6.48M
-
Number of buys
-
36
-
Number of sells
-
-19
-
Price
-
$4.59
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2020
71 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2020.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 79.8M outstanding shares and own 17.73% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.83M shares), VANGUARD GROUP INC (2.26M shares), ICONIQ Capital, LLC (1.71M shares), Tieton Capital Management, LLC (1.02M shares), Uniplan Investment Counsel, Inc. (767K shares), STATE STREET CORP (731K shares), GEODE CAPITAL MANAGEMENT, LLC (613K shares), NORTHERN TRUST CORP (505K shares), MORGAN STANLEY (466K shares), and Sycale Advisors (NY) LLC (360K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.